Clinical Trials on Infezioni da enterovirus
Total 0 results
Nothing found
Sponsors and Collaborators
- Health Parametrics Inc.
- Jeffrey W. Clark, MD
- CTC Bio, Inc.
- Wushan County People's Hospital
- European Network For Smoking and Tobacco Prevention
- Mitchell Scheiman
- Kawin Technology Share-holding Co., Ltd.
- Rex Bionics Plc
- Marilia Medicine School
- New York State Health Foundation
- The Third Hospital of Changsha
- Honda R and D Americas, Inc.
- John Granton
- Ionis Pharmaceuticals
- Medtronic Atrial Fibrillation Solutions
- Jeffrey Rudolph
- Zahra Rabbani Khah
- Montreal Neurological Institute and Hospital
- MingSight Pharmaceuticals Pty Limited
- Northern California Melanoma Center
- View Full List
Medical Conditions
- Advanced Esophageal Cancers
- Locally Advanced NSCLC
- ACTH-Secreting Pituitary Adenoma
- Liver Hemangioma
- Fasting, Diet, Chemotherapy, Toxicity
- Periferal Arterial Occlusive Disease, PAOD
- HDT-AHCT
- Renal Cancer Metastatic
- Primary Generalized Dystonia
- Hyperthyroidism, Autoimmune
- Brain MRI
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Pregnancy-Related Condition, Unspecified
- LSIL
- H.Pylori Infection
- Waldenstrom's Macroglobulinemia Recurrent
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- Pancreatic Neoplasms
- Metastatic Spine Lesions
- Ascaris Suum
- View Full List
Drug Interventions
- Levobupivacaine, clonidine
- Bendamustine
- Fludarabine
- Pentostatin
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- CKD-519
- Hydroxychloroquine
- Toripalimab plus Anlotinib
- AZD7798
- ESK981
- Postoperative analgesia management
- Rifaximin
- Levcromakalim
- Nimotuzumab
- 200 µg doxorubicin-containing MNA
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Ombrabulin (AVE8062)
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- View Full List
CROs by country
- Contract Research Organizations in Benin
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Congo
- Contract Research Organizations in Egypt
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Israel
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Uganda
- CRO list by country